Login

Balance sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Jun 30, 2024
Q2 FY2024
As of Mar 31, 2024
Q1 FY2024
As of Dec 31, 2023
Q4 FY2023
As of Sep 30, 2023
Q3 FY2023
As of Jun 30, 2023
Q2 FY2023
As of Mar 31, 2023
Q1 FY2023
As of Dec 31, 2022
ASSETS
Current Assets
Cash
Prepaid expenses
Investments held in trust account
Deferred offering costs associated with initial public offering
Total Assets
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accrued expenses
Note payable - related party
Forward Purchase Agreement liability
Total current liabilities
Total Liabilities
Ordinary shares subject to possible redemption, 2,081,432 and 6,900,000 shares, respectively, at redemption value of $10.97 and $10.52 per share, respectively
SHAREHOLDERS' EQUITY (DEFICIT)
Ordinary shares, $0.000125 par value; 800,000,000 shares authorized; 2,392,000 shares issued and outstanding (1)
Additional paid-in capital
(Accumulated deficit)/retained earnings
Total Shareholders' Equity (Deficit)
Total Liabilities and Shareholders' Equity (Deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support